Cosmeceuticals
Sold to patients from the physician's office or via the Internet, physician-dispensed (PD) skincare, eyelash and skin lightening products are growing quickly as both consumers and physicians increasingly understand the benefits of these products. Particularly as manufacturers continue to introduce ever more efficacious products incorporating advanced, new technologies, the products are viewed as a means to enhance office-based procedures and/or achieve results not otherwise possible. They also offer physicians an additional revenue stream which can be quite significant for offices with large re-order businesses. In 2010, total global sales of physician-dispensed skincare products, eyelash growth products and skin lighteners, reached $606.8 million. Through 2015, these total market sales will rise by 13.8% per year, with particularly strong growth in the physician-dispensed skin lightening segment…

This report was compiled from in-depth interviews with leading industry executives, a recent Medical Insight survey of physicians and other proprietary data. It provides detailed insight on both the physician-dispensed cosmeceutical and the physician dispensed eyelash product markets. it offers:

• estimated global sales for each of three market segments (physician-dispensed skin care topicals, physician-dispensed eyelash products and physician-dispensed skin lighteners) for each year from 2010 to 2015;
• a discussion of the unique market drivers and restraints from the physician perspective;
• comprehensive analysis of active ingredients, new products and product development trends;
• product charts describing major products;
• expanded graphical images;
• detailed profiles of the top 17 manufacturers, including Allergan, Athena Cosmetics, Innovative Skincare, Jan Marini, La Canada Ventures, La-Roche Posay, MD Formulations, Obagi, PhotoMedex, Revance, SkinCeuticals, SkinMedica, Stiefel Laboratories and Young Pharmaceuticals;